Search clinical trials for: Cefazolin with Daptomycin

Total 17510 results

Chang Gung Memorial Hospital

Not yet recruiting

Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial

Periprosthetic Joint Infection

Taiwan
Universidade do Vale do Sapucai

Completed

Antibiotic Prophylaxis in Gynecologic Laparoscopy

Infection Secondary to Surgical Procedure

Brazil
Vancouver Island Health Authority

Recruiting

Ceftriaxone as Home IV for Staph Infections

Abscess | Staphylococcal Infections | Diabetic Foot Infection | Osteomyelitis | Vertebral Osteomyelitis | CNS Infection | Septic Arthritis | Coagulase Negative Staphylococcal Infection

Canada
Hormozgan University of Medical Sciences

Completed

Effect of Cefazolin and Normal Saline Irrigation on Surgical Site Infections (SSIs)

Surgical Site Infections

Iran, Islamic Republic of
Nantes University Hospital

Completed

Tissue and Plasma Pharmacokinetics of Cefazolin in Antibiotic Prophylaxis in Bariatric Surgery (Cefasleeve)

Bariatric Surgery

France
HaEmek Medical Center, Israel

Completed

Prophylactic Antibiotic in Treatment of Fingertip Amputation

Infection Rate After Fingertip Amputation

Israel
Hospices Civils de Lyon

Unknown

Description of Eosinophilic Pneumonia in BJI/PJI Treated by Daptomycin

Bone and Joint Infection | Dactinomycin Adverse Reaction

France
National Institute of Allergy and Infectious Diseases...

Completed

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

Staphylococcal Bacteraemia

United States, Canada
Infectious Diseases Physicians, Inc.
Johns Hopkins University

Completed

Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

Prosthetic Joint Infection | Osteomyelitis | Septic Arthritis | Bone Infection | Joint Infection

United States
Daniela Francescato Veiga

Recruiting

Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty

Wound Infection | Anti-bacterial Agents | Mammaplasty | Prophylaxis | Plastic Surgery

Brazil
CR-CSSS Champlain-Charles-Le Moyne

Suspended

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer (BRP30)

Prostate Cancer

Canada
Hospices Civils de Lyon

Recruiting

Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections (PKTOXDAP)

Bone and Joint Infection | Dactinomycin Adverse Reaction

France
Duke University
National Institutes of Health (NIH)

Completed

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection (Bacteremia)

Bacteremia

United States, Spain
Cubist Pharmaceuticals LLC

Terminated

Cubicin(R) for Complicated Post-surgical Wound Infections (PSW)

Wound Infections
Abdul El-Rabbany

Recruiting

Antibiotics for Prevention of Infection Following Orthognathic Surgery

Orthognathic Surgical Site Infection

Canada
B. Braun Medical Inc.
Parexel

Completed

Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX (2 Cef)

Infection

United States
Cubist Pharmaceuticals LLC

Terminated

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Gram-Positive Bacterial Infections
Cumberland Pharmaceuticals

Terminated

A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial

Bacteremia

United States
B. Braun Medical Inc.

Terminated

Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects

Postoperative Infection

United States
B. Braun Medical Inc.

Completed

Pediatric Cefazolin PK Study

Infections

United States
University of Missouri-Columbia

Completed

Antibiotic Prophylaxis in Orthopaedic Traumatology

Wounds and Injuries | Fractures, Closed

United States
Cubist Pharmaceuticals LLC

Completed

Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)

End-Stage Renal Disease
Cubist Pharmaceuticals LLC

Terminated

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Infective Endocarditis

United States
Cubist Pharmaceuticals LLC

Completed

Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics

Gram-positive Bacterial Infections

United States
Cubist Pharmaceuticals LLC

Completed

Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia

Pneumonia, Bacterial
Aultman Health Foundation

Completed

Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy

Wound Infection

United States
Cubist Pharmaceuticals LLC

Completed

Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

End-stage Renal Disease | Renal Failure Chronic Requiring Hemodialysis

United States
Stanford University

Completed

Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients

Aortic Valve Disorder | Congenital Heart Diseases

United States
Phillip Brian Smith
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates

Sepsis | Prematurity

Brazil
Cubist Pharmaceuticals LLC

Completed

Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae

Pneumonia, Bacterial
Cubist Pharmaceuticals LLC

Completed

PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections

Gram Positive Infection | Concurrent Antibiotic Treatment

United States
Cubist Pharmaceuticals LLC

Completed

Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus

Bacteremia | Bacterial Endocarditis
Sonescence, Inc.
University of Southern California

Unknown

Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds

Non-healing Wound | Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Brigham and Women's Hospital

Completed

Efficacy of Post-operative Antibiotic Prophylaxis for Thoracic Surgery Requiring Tube Thoracostomy

Antibiotic Prophylaxis

United States
University Hospital, Caen

Completed

Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Peritoneal Infection (DAPTODP)

Peritoneal Infection

France
Merck Sharp & Dohme LLC

Completed

A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

Staphylococcal Infection
Tehran University of Medical Sciences

Completed

Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients

Laryngeal Cancer

Iran, Islamic Republic of
Merck Sharp & Dohme LLC

Completed

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

Skin Diseases, Infectious | Bacteremia | Soft Tissue Infections

Japan
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy

Unspecified Childhood Solid Tumor, Protocol Specific | Neutropenia | Unspecified Adult Solid Tumor, Protocol Specific | Infection

United States
Cubist Pharmaceuticals LLC

Terminated

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Soft Tissue Infections

United States
Cubist Pharmaceuticals LLC

Terminated

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia (HDSAB)

Infective Endocarditis | Endocarditis, Bacterial

United States
Meir Medical Center

Not yet recruiting

Prophylactic Antibiotic After Perineal Tear (PATPET)

Puerperal Infection

Israel
CHU de Quebec-Universite Laval

Completed

Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy

Breast Cancer

Canada
Michael Stitely

Completed

Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery

Obesity | Wound Infection | Cesarean Delivery

United States
University of Maryland, Baltimore
Cubist Pharmaceuticals LLC

Completed

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

Fasciitis, Necrotizing | Fournier's Gangrene | Severe Necrotizing Skin and Soft Tissue Infections

United States
Lundquist Institute for Biomedical Innovation at...
Western University of Health Sciences; Hartford Hospital; Cubist Pharmaceuticals...

Completed

Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery

Staphylococcus Aureus | Surgical Site Infection | Late Effects of Surgery

United States
University of Michigan
Agency for Healthcare Research and Quality (AHRQ)

Recruiting

Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis (MorphAbxPKSurg)

Surgical Prophylaxis

United States
Istanbul University

Completed

Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device (TIVAD)

Solid Tumor

Turkey
B. Braun Medical Inc.

Completed

Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults (3gCefPK)

Infections

United States
University of Pittsburgh

Completed

Peri-operative Cefazolin Prophylaxis at Time of Cesarean Delivery in the Obese Gravida

Obesity | Pregnancy

United States

Search clinical trials for: Cefazolin with Daptomycin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations